Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 20, 2011

View Archived Issues

Small-molecule inhibitors of ezrin developed to target bone cancer

U.S. study uncovers candidate SNPs associated with susceptibility to cold sores

Vertex Pharmaceuticals synthesizes novel products

Isis Pharmaceuticals expands pipeline

DSMB recommends continuation of VISTA-16 trial

Vernalis and Lundbeck collaboration reaches second milestone

Neovacs completes recruitment in phase II TNF-Kinoid trial

New inhibitor of cyclin-dependent kinase 9 shows preclinical potential in CLL

Chugai Pharmaceutical presents new MEK 1 inhibitor

Novel biomarker for B-cell lymphoma discovered in Japan

New prodrugs of a coagulation factor VIIa inhibitor designed by Eisai

Novel GPR52 receptor agonists disclosed by Takeda Pharmaceutical

U.K. team presents novel cyclophilin inhibitors

New chelating cyclopeptides prepared by French group

Impax advances IPX-159 to phase IIb testing

FDA clears assay to help predict prognosis of patients with heart failure

Millennium Pharmaceuticals patents new histone deacetylase 6 inhibitors

Sanofi sells Dermik

Rib-X Pharmaceuticals reports data from phase IIb delafloxacin study

NeurogesX gives update on Qutenza sNDA

Gilead Sciences submits sNDA for Truvada

StemCells completes treatment of first cohort in phase I/II spinal cord injury trial

Dicerna and Kyowa Hakko Kirin select DsiRNA candidate for development

ThromboGenics and BioInvent complete enrollment in phase IIb TB-402 study

FDA does not require REMS program for Korlym in Cushing's syndrome

Vertex gives update on Kalydeco NDA and MAA

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...